My passion is to advance research, development, and commercialization of the cutting edge therapies of tomorrow, including Cell and Gene Therapies. I am an experienced scientist and business leader with expertise in basic and applied biological and cell therapy R&D as well as in management, technology, and commercialization. My background is interdisciplinary - biological research, biomedical engineering, commercialization, management, and bio manufacturing. I strive to leverage these skills to be an instrumental team player in bringing novel life saving therapies from bench-to-bedside.
VP, Business Head of Cell, Gene and Nucleic Acids Franchises at Resilience
Post doctorate, Harvard-MIT Biomedical Engineering Center HST, Tissue Engineering, Cell Therapy